Sabrina Martucci Johnson's Insider Trades & SAST Disclosures
Sabrina Martucci Johnson's most recent trade in Dare Bioscience Inc was a trade of 107,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 28, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sabrina Martucci Johnson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dare Bioscience Inc | Sabrina Martucci Johnson | Director, Chef Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 107,000 | 107,000 | - | - | Employee Stock Option (right to buy) | |
| ATAI Life Sciences N.V. | Sabrina Martucci Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 103,000 | 103,000 | - | - | Stock Option | |
| Dare Bioscience Inc | Sabrina Martucci Johnson | Director, Chef Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 750,000 | 750,000 | - | - | Employee Stock Option (right to buy) | |
| ATAI Life Sciences N.V. | Sabrina Martucci Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 64,000 | 64,000 | - | - | Stock Option | |
| Dare Bioscience Inc | Sabrina Martucci Johnson | Director, Chef Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 750,000 | 750,000 | - | - | Stock Option (right to buy) | |
| ATAI Life Sciences N.V. | Sabrina Martucci Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 64,000 | 64,000 | - | - | Stock Option | |
| Aethlon Medical Inc | Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. | 31 Mar 2022 | 2,430 | 33,642 (0%) | 0% | 1.5 | 3,548 | Common Stock |
| Dare Bioscience Inc | Sabrina Martucci Johnson | Director, Chef Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 628,400 | 628,400 | - | - | Stock Option (right to buy) | |
| ATAI Life Sciences N.V. | Sabrina Martucci Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 128,000 | 128,000 | - | - | Stock Option | |
| Aethlon Medical Inc | Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.91 per share. | 30 Jun 2021 | 2,430 | 40,932 (0%) | 0% | 4.9 | 11,931 | Common Stock |
| Aethlon Medical Inc | Sabrina Martucci Johnson | Director | Grant, award, or other acquisition of securities at price $ 2.06 per share. | 31 Mar 2021 | 24,295 | 43,362 (0%) | 0% | 2.1 | 50,048 | Common Stock |
| Aethlon Medical Inc | Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 31 Mar 2021 | 2,575 | 19,067 (0%) | 0% | 2.0 | 5,227 | Common Stock |
| Dare Bioscience Inc | Sabrina Martucci Johnson | Director, Chef Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 525,000 | 525,000 | - | - | Stock Option (right to buy) | |
| Aethlon Medical Inc | Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.35 per share. | 30 Sep 2020 | 2,389 | 24,217 (0%) | 0% | 1.3 | 3,225 | Common Stock |
| Aethlon Medical Inc | Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 30 Jun 2020 | 2,389 | 25,677 (0%) | 0% | 2.0 | 4,850 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges